Overactive RAS signaling is definitely widespread in juvenile myelomonocytic leukemia (JMML) as well as the myeloproliferative variant of chronic myelomonocytic leukemia (MP-CMML) in individuals, and both are refractory to typical chemotherapy. in dealing with sufferers with JMML and MP-CMML. Launch Hyperactive RAS signaling continues to be implicated in both juvenile myelomonocytic leukemia (JMML) as well… Continue reading Overactive RAS signaling is definitely widespread in juvenile myelomonocytic leukemia (JMML)